Psychotic symptoms induced in mice by the intravenous administration of solutions of 3,4-dihydroxyphenylalanine (DOPA).
D061605:Administration, Intravenous; D000818:Animals; D004295:Dihydroxyphenylalanine / Q000633:toxicity*; D051379:Mice; D011600:Psychopharmacology; D011618:Psychotic Disorders; D012996:Solutions
D012996:Solutions; D004295:Dihydroxyphenylalanine
DOPA/toxicology; PSYCHOPHARMACOLOGY/experimental